Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Complete title: Phase II Study of everolimus for recurrent or progressive low-grade gliomas in children

Research Study Number PNOC001
 
Principal Investigator Sarah Leary
 
Phase II

Research Study Description

This is an open label study of everolimus in children with recurrent or progressive low-grade glioma.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number PNOC001
 
Contact Advanced Therapeutics Study Line
 
Telephone 206/987-2553
 
E-mail
 

Keywords: Brain Cancer; Glioma; Pediatric Cancers, Miscellaneous; Solid Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms; Neuroectodermal Tumors

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials